Capnography Devices Market

Market Overview:

The global capnography devices market size reached US$ 384.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 548.2 Million by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.

Capnography devices refer to various medical equipment that are used for measuring the amount of carbon dioxide (CO₂) present in the patient’s bloodstream. They measure the inhaled and exhaled concentration of CO₂ in the body. The devices are used for patients undergoing anesthesia to ensure that they are receiving ample oxygen throughout the surgical procedure. These devices are commonly available in handheld, standalone and multi-parameter variants based on main-, side- and micro-stream technologies. They also aid in diagnosing the cause of respiratory distress, providing real-time feedback on treatment effects and detecting shocks.

The increasing prevalence of respiratory and chronic obstructive pulmonary diseases (COPD), such as pulmonary embolism and asthma, is one of the key factors driving the growth of the market. These devices are also being used for monitoring patients under intensive care who are suffering from the coronavirus disease (COVID-19). Furthermore, the rising geriatric population, which is more susceptible to lung disorders, is also providing driving the market growth. Capnography devices are widely being used for operative and post-operative care of patients and are commonly used in operation, recovery and critical rooms, wards and ambulances. Various product innovations, such as the development of technologically advanced devices that offer ease-of-connection, convenient sterilization and enable accurate monitoring of non-intubated substances, are acting as another growth-inducing factor. The market is further driven by the launch of variants that are integrated with photodetectors, molecular correlation spectroscopy and miniaturized multi-gas monitors that are highly accurate and have an adjustable flow rate. Other factors, including significant improvements in the healthcare infrastructure, along with the development of portable and point-of-care (POC) capnography devices, are projected to create a positive outlook for the market. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global capnography devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, product type, technology, application and end-user.

Breakup by Product:

• Capnometers
• Accessories
   

Breakup by Product Type:

• Handheld
• Conventional
   

Breakup by Technology:

• Main-stream
• Side-stream
• Micro-stream
   

Breakup by Application:

• Trauma and Emergency Care
• Cardiac Care
• Respiratory Monitoring
• Others
   

Breakup by End-User:

• Hospitals and Clinics
• Ambulatory Surgery Centers (ASCs)
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Becton, Dickinson and Company (BD), Burtons Medical Equipment Ltd., Opto Cardiac Care Limited (Criticare Technologies Inc.), FUTEK Advanced Sensor Technology, Inc., DiaMedica Therapeutics, Inc. (DMAC), Drägerwerk AG, EDAN Instruments Inc., Hill-Rom Services Inc., Infinium Medical, Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic Inc., Nihon Kohden Corporation, Nonin Medical Inc., Smiths Medical MD, Inc. and Zoe Medical Incorporated. etc.

Report Coverage: